Performance
Trailing returns
| 1 day |
| -0.03% | |||
| 1 week | +1.18% |
| |||
| 4 week | +5.47% |
| |||
| 3 month | +7.97% |
| |||
| YTD | +13.93% |
| |||
| 1 year | +31.08% |
| |||
| 3 years* | +15.00% |
| |||
| 5 years* | +5.29% |
| |||
| *annualized | |||||
| Best 3 month return | +25.64% | |
| Worst 3 month return | -29.21% |
Morningstar statistics
Morningstar category: Moderate Allocation
| Return | Risk | Rating | |
| 3 years | High | High |
 
|
| 5 years | Average | High |
|
| 10 years | Above Average | High |
|
| Overall | Above Average | High |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 13.05B | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 0.53% | |
| Management fee | - | |
| Fund family | Dodge & Cox |
Asset allocation
| Cash | 6.85% | |
| Stocks | 73.73% | |
| Bonds | 19.22% | |
| Preferred | 0.19% | |
| Other | 0.00% |
Purchase information
| Initial | US$2,500 | |
| Additional | US$100 | |
| IRA Initial | US$1,000 | |
| AIP Initial | US$2,500 | |
| AIP Additional | US$100 |
88.48-0.03(-0.03%)
May 20, 4:00PM EDT
Overall Morningstar RatingTM
Description
The investment seeks regular income, conservation of principal, and an opportunity for long-term growth of principal and income. The fund invests in a diversified portfolio of common stocks, preferred stocks, and fixed income securities. It primarily invests in companies that, in Dodge & Cox's opinion, appear to be temporarily undervalued by the stock market and have a favorable outlook for long-term growth. While the mix of equity and fixed income securities will vary depending on Dodge & Cox's outlook on the markets, under normal circumstances no more than 75% (and no less than 25%) of total assets will be invested in equity securities.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
Steven Voorhis (Started: May 1, 2006)
Anthony Brekke (Started: May 1, 2008)
Adam Rubinson (Started: Feb 15, 2010)
Lucinda Johns (Started: May 1, 2012)
Philippe Barret, Jr. (Started: May 1, 2013)
Diana Strandberg (Started: Jan 1, 2005)
Wendell Birkhofer (Started: Jan 1, 2002)
C. Cameron (Started: Jan 1, 1992)
Charles Pohl (Started: Jan 1, 1992)
Dana Emery (Started: Jan 1, 1986)
David Hoeft (Started: Jan 1, 2002)
James Dignan (Started: May 1, 2002)
John Gunn (Started: Jan 1, 1977)
Gregory Serrurier (Started: Jan 1, 1996)
Thomas Dugan (Started: Jan 1, 1994)
Kent Radspinner (Started: May 1, 1996)
Larissa Roesch (Started: May 1, 1998)
Robert Thompson (Started: May 1, 1992)
Steven Voorhis (Started: May 1, 2006)
Anthony Brekke (Started: May 1, 2008)
Adam Rubinson (Started: Feb 15, 2010)
Lucinda Johns (Started: May 1, 2012)
Philippe Barret, Jr. (Started: May 1, 2013)
Diana Strandberg (Started: Jan 1, 2005)
Wendell Birkhofer (Started: Jan 1, 2002)
C. Cameron (Started: Jan 1, 1992)
Charles Pohl (Started: Jan 1, 1992)
Dana Emery (Started: Jan 1, 1986)
David Hoeft (Started: Jan 1, 2002)
James Dignan (Started: May 1, 2002)
John Gunn (Started: Jan 1, 1977)
Gregory Serrurier (Started: Jan 1, 1996)
Thomas Dugan (Started: Jan 1, 1994)
Kent Radspinner (Started: May 1, 1996)
Larissa Roesch (Started: May 1, 1998)
Robert Thompson (Started: May 1, 1992)
Dodge & Cox Worldwide Investments Ltd., 111 Buckingham Palace Road
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 4.69 | -1.08 | -1.52 | -2.32 | |
| Beta* | 1.27 | 1.34 | 1.36 | 1.31 | |
| Mean annual return | 1.50 | 0.91 | 0.54 | 0.69 | |
| R-squared* | 96.89 | 96.25 | 95.97 | 93.62 | |
| Standard deviation | 9.03 | 13.28 | 17.40 | 13.12 | |
| Sharpe ratio | 1.98 | 0.82 | 0.35 | 0.50 | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| 10 Year U.S. Treasury Note � Short Position | 3.27% | |
| Hewlett-Packard Co (HPQ) | 2.98% | |
| Wells Fargo & Co (WFC) | 2.78% | |
| Capital One Financial Corp (COF) | 2.68% | |
| Comcast Corp Class A (CMCSA) | 2.54% | |
| Microsoft Corporation (MSFT) | 2.30% | |
| Sprint Nextel Corp (S) | 2.28% | |
| Time Warner Inc (TWX) | 2.27% | |
| Sanofi ADR (SNY) | 2.18% | |
| Merck & Co Inc (MRK) | 2.15% |